Disc Medicine, Inc. (IRON) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
About Disc Medicine, Inc.
Disc Medicine, Inc. (IRON) stock trades at $74.51 with a market capitalization of $2.86B. The stock is valued at a negative price-to-earnings (P/E) ratio of -9.92, reflecting a net loss over the last twelve months, price-to-book of 3.93, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $40.00 and $99.50, and currently trades 25.1% below its 52-week high.
On profitability, Disc Medicine, Inc. generates a return on equity (ROE) of -37.17% (negative, reflecting a net loss), return on capital employed of -38.21%.
Disc Medicine, Inc. by the numbers, 2020–2025
Between 2020 and 2025 Disc Medicine, Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-212.0M.
On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-247.0M.
Borrowings fell from $22.0M to $2.0M, cash from operations was $-180.0M in the latest year, positive in 0 of the last 6.
Return on equity has averaged -9.1% over five years, and was -28.6% in the most recent year.
The share price itself has compounded at -23.3% a year over five years, 27.3% over three, 47.0% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Disc Medicine, Inc. (IRON) — frequently asked questions
What is Disc Medicine, Inc. (IRON) stock price today?
Disc Medicine, Inc. (IRON) is currently trading at $74.51, down 0.69% today.
What is IRON P/E ratio?
Disc Medicine, Inc.'s P/E ratio is -9.92. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is IRON return on equity (ROE)?
Disc Medicine, Inc.'s return on equity (ROE) is -37.17%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Disc Medicine, Inc.'s market cap?
Disc Medicine, Inc. has a market capitalization of $2.86B.
Does IRON pay a dividend?
Disc Medicine, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does IRON carry?
Disc Medicine, Inc. has a debt-to-equity ratio of 0.09. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is IRON's profit margin?
Disc Medicine, Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is IRON in?
Disc Medicine, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is IRON listed on?
Disc Medicine, Inc. trades on NASDAQ under the ticker IRON.
What is IRON's 52-week range?
Over the last year Disc Medicine, Inc. has traded between $40.00 and $99.50.
Related Healthcare Stocks
Popular Stocks
Screens IRON currently matches
On the figures above, Disc Medicine, Inc. passes the filters for 5 of our ready-made screens, among them Low Debt Stocks, Stocks Under $100, Mid Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.